Acquisition Opportunity

Telehealth Brand Assets Available for Acquisition
Transcend Company operates a direct-pay telehealth platform, connecting consumers with licensed professionals to help achieve wellness goals in areas including hormone therapy, peptide therapy, weight management, sexual health and longevity. Transcend also supplies the operational infrastructure behind those relationships, including intake, lab and pharmacy fulfillment coordination, and ongoing patient support.
Asset Type
Telehealth Brand Assets
Key Date
Bids due October 9, 2026
A Brand Built to Scale
Transcend, founded in 2020, is built around a guided, lab-first experience. Each care relationship begins with a starter health evaluation: a clinical intake, a comprehensive blood panel and a review of the results with a licensed provider by video or phone. Where medically appropriate, the provider develops a personalized care plan. Prescribed medications ship directly to the consumer’s home through partner pharmacies, and a dedicated wellness specialist provides ongoing support and follow-up.
The company operates on a direct-pay model, allowing consumers to pay with HSA or FSA funds. Services are available to adults in all 50 states and the District of Columbia.
The platform supports a broad range of service lines:
- Hormone therapyHormone replacement and testosterone therapy for men and women
- Peptide therapyPrograms focused on recovery, performance and longevity
- Weight managementMetabolic health and weight-loss programs
- Sexual healthDedicated programs for both men and women
- Performance and longevityAthletic performance, healing and recovery, and healthy aging
- Specialty programsCognitive clarity, thyroid function, fertility, men’s hair growth, and skin care
- Additional offeringsStandalone diagnostic lab panels, nutritional counseling, and a selection of third-party nutritional supplements
Connecting Consumers with Care
Transcend's core function is connecting consumers with medical practices. Consumers find care through the Transcend brand and its owned channels rather than through physician referral or insurance networks. This allows an affiliated practice to reach a national patient base. The brand has grown largely through social media and athlete partnerships, reaching a performance-minded audience focused on hormone optimization, recovery, body composition, and healthy aging. Its flagship Instagram account has built a meaningful following, making the Transcend name a recognized presence in the fast-growing longevity category.
Available Assets
- Trademarks
- Social Media Accounts
- Domain Names
All data, including but not limited to protected health information (PHI) and personally identifiable information (PII), is excluded from the sale.
Bid Deadline
Bids are due October 9, 2026 at 12:00 p.m. Eastern Time / 11:00 a.m. Central Time / 9:00 a.m. Pacific Time.
Contact Silhouette Advisors for more information.
Contact UsSilhouette Advisors LLC is acting as sale agent for TCI (ABC), LLC, solely in its capacity as assignee for the benefit of creditors of Transcend Company, Inc. All assets are sold “as is, where is,” without representations or warranties of any kind.